A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.
暂无分享,去创建一个
R. Clemmer | B. Setnik | G. Pixton | K. Sommerville | V. Goli | S. Arora | P. Meisner | J. Hudson | Drass Michael